FDA updates labeling for MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE FDA Approval Dec. 31, 2025, 13:45 UTC 38 0 comments Labeling changes approved for INTL MEDICATION. Active ingredient: MEPERIDINE HYDROCHLORIDE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for BUTORPHANOL TARTRATE FDA Approval Dec. 31, 2025, 13:45 UTC 34 0 comments Labeling changes approved for HIKMA. Active ingredient: BUTORPHANOL TARTRATE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for METHADONE HYDROCHLORIDE FDA Approval Dec. 31, 2025, 13:45 UTC 32 0 comments Labeling changes approved for HIKMA. Active ingredient: METHADONE HYDROCHLORIDE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for ACETAMINOPHEN AND CODEINE PHOSPHATE FDA Approval Dec. 31, 2025, 13:45 UTC 37 0 comments Labeling changes approved for PHARMOBEDIENT. Active ingredient: ACETAMINOPHEN; CODEINE PHOSPHATE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for BUTORPHANOL TARTRATE FDA Approval Dec. 31, 2025, 13:45 UTC 32 0 comments Labeling changes approved for HIKMA. Active ingredient: BUTORPHANOL TARTRATE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for BUTORPHANOL TARTRATE PRESERVATIVE FREE FDA Approval Dec. 31, 2025, 13:45 UTC 22 0 comments Labeling changes approved for HOSPIRA. Active ingredient: BUTORPHANOL TARTRATE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for ACETAMINOPHEN AND CODEINE PHOSPHATE FDA Approval Dec. 31, 2025, 13:45 UTC 34 0 comments Labeling changes approved for FOSUN PHARMA. Active ingredient: ACETAMINOPHEN; CODEINE PHOSPHATE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for FENTANYL-100 FDA Approval Dec. 31, 2025, 13:45 UTC 25 0 comments Labeling changes approved for SPECGX LLC. Active ingredient: FENTANYL. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for ACETAMINOPHEN AND CODEINE PHOSPHATE FDA Approval Dec. 31, 2025, 13:45 UTC 31 0 comments Labeling changes approved for RHODES PHARMS. Active ingredient: ACETAMINOPHEN; CODEINE PHOSPHATE. Decision date: 12/22/2025 Comment Full text
FDA updates labeling for HYDROCODONE BITARTRATE AND IBUPROFEN FDA Approval Dec. 31, 2025, 13:45 UTC 27 0 comments Labeling changes approved for ACTAVIS LABS FL INC. Active ingredient: HYDROCODONE BITARTRATE; IBUPROFEN. Decision date: 12/22/2025 Comment Full text